You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PASC

Showing 1 - 25 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post Acute Sequelae Covid-19 Hyposmia Trial in Durham (drug, other, device)

Not yet recruiting
  • Post Acute Sequelae Covid-19 Hyposmia
  • Durham, North Carolina
    Duke University Medical Center
Jul 24, 2023

Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)

Not yet recruiting
  • Long COVID
  • +2 more
  • BrainHQ/Active Comparator Activity
  • +4 more
  • Houston, Texas
  • +1 more
Aug 1, 2023

Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID Trial in Stanford (Nirmatrelvir, Placebo, Ritonavir)

Recruiting
  • Post-acute Sequelae of SARS-CoV-2 Infection
  • Long COVID
  • Stanford, California
    Stanford University
Dec 12, 2022

Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose

Not yet recruiting
  • Long COVID
  • +2 more
  • Adipose Tissue Biopsy
  • Steady State Plasma Glucose (SSPG) Test
  • Palo Alto, California
  • +1 more
Apr 27, 2023

Long COVID Trial (Paxlovid, Placebo)

Not yet recruiting
  • Long COVID
  • (no location specified)
Oct 24, 2022

Post-acute Sequelae of COVID-19, Depressive Symptoms, Cognitive Dysfunction Trial (CI-581a, CI-581b)

Not yet recruiting
  • Post-acute Sequelae of COVID-19
  • +2 more
  • (no location specified)
Jan 24, 2023

Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)

Not yet recruiting
  • Long COVID
  • +2 more
  • BrainHQ/Active Comparator Activity
  • +4 more
  • Houston, Texas
  • +1 more
Aug 1, 2023

COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of

Enrolling by invitation
  • COVID-19
  • +2 more
  • Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
  • Kunming, Yunnan, China
    Sheng'Ai Traditional Medicine Hospital
Sep 22, 2023

Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection Trial (Comprehensive Rehabilitation, Augmented

Not yet recruiting
  • Post-Acute COVID-19
  • +7 more
  • Comprehensive Rehabilitation
  • Augmented Usual Care
  • (no location specified)
Nov 28, 2023

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO

Recruiting
  • Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
  • PET Tracer
  • +2 more
  • New York, New York
    NYU Langone Health
Nov 7, 2022

Post-COVID-19 Syndrome Trial in Geneva (Temelimab 54mg/kg, Placebo)

Not yet recruiting
  • Post-COVID-19 Syndrome
  • Temelimab 54mg/kg
  • Placebo
  • Geneva, Switzerland
    Geneva University Hospital
Aug 9, 2022

Long COVID Trial in Boston (whole body hyperthermia)

Not yet recruiting
  • Long COVID
  • whole body hyperthermia
  • Boston, Massachusetts
    Depression Clinical and Research Program
Jul 5, 2023

COVID-19 Trial in Milwaukee (Lactobacillus Plantarum 299v in fermented oat drink, Heat-Killed Placebo control fermented drink)

Recruiting
  • COVID-19
  • Lactobacillus Plantarum 299v in fermented oat drink
  • Heat-Killed Placebo control fermented drink
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jun 22, 2022

Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)

Not yet recruiting
  • Long COVID-19
  • Long COVID
  • Paxlovid 25 day dosing
  • +2 more
  • (no location specified)
Jul 25, 2023

Long COVID, Dysautonomia Trial in Los Angeles (Mindfulness - Mindful Awareness Practices ( MAPs))

Recruiting
  • Long COVID
  • Dysautonomia
  • Mindfulness - Mindful Awareness Practices ( MAPs)
  • Los Angeles, California
    UCLA Health
Jan 20, 2023

Post-acute COVID-19 Syndrome Trial in Cleveland (Vitamin K2 (MK-7), Vitamin D3)

Recruiting
  • Post-acute COVID-19 Syndrome
  • Vitamin K2 (MK-7)
  • Vitamin D3
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jun 9, 2022

Dysexecutive Syndrome, Post-Acute Sequelae of COVID-19 Trial in Charlestown (Active tDCS, Sham tDCS)

Not yet recruiting
  • Dysexecutive Syndrome
  • Post-Acute Sequelae of COVID-19
  • Active tDCS
  • Sham tDCS
  • Charlestown, Massachusetts
    Massachusetts General Hospital
Apr 4, 2022

Skeletal Muscle in PASC Patients

Recruiting
  • LONG-COVID
  • Post-acute Sequelae of COVID-19
  • Bike exertion test
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam university medical centre AMC
Feb 3, 2022

Post-acute Sequelae SARS-CoV-2 Infection (PASC) Trial in Minneapolis (Active tDCS, Sham tDCS)

Not yet recruiting
  • Post-acute Sequelae SARS-CoV-2 Infection (PASC)
  • Active tDCS
  • Sham tDCS
  • Minneapolis, Minnesota
    University of Minnesota
Jan 2, 2023

Effect of Apollo Wearable on Long COVID-19 Symptoms.

Recruiting
  • Post-acute Sequelae of SARS-COV-2 Infection
    • Pittsburgh, Pennsylvania
      The Board of Medicine
    Oct 25, 2023

    Pain in Long COVID-19: The Role of Sleep

    Recruiting
    • Long COVID
    • No intervention
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Nov 3, 2022

    Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection Trial in Oxford (AXA1125, Placebo)

    Active, not recruiting
    • Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
    • Oxford, United Kingdom
      Oxford University Hospitals NHS Foundation Trust
    Jun 5, 2022

    Long COVID Trial (Adipose Tissue Harvest, ATCell)

    Not yet recruiting
    • Long COVID
    • Adipose Tissue Harvest
    • ATCell
    • (no location specified)
    Dec 28, 2022

    Parkinson Disease Trial in San José (PASC transplantation (25 million PASCs/patient), Control)

    Active, not recruiting
    • Parkinson Disease
    • PASC transplantation (25 million PASCs/patient)
    • Control
    • San José, Costa Rica
    • +1 more
    Nov 28, 2023

    COVID-19, SAR Trial in Hanover (CBDRA60 supplement, Placebo)

    Not yet recruiting
    • COVID-19
    • SAR
    • CBDRA60 supplement
    • Placebo
    • Hanover, Michigan
      Anewsha Therapeutics / Comco R&D
    Feb 18, 2022